Open AccessSecretion of Toxoplasma gondii ‐specfic antibody in vitro by peripheral blood mononuclear cells as a new marker of acute toxoplasmosis
Author(s) -
VENDRELL J. P.,
PRATLONG F.,
DECOSTER A.,
BOULOT P.,
CONGE A. M.,
DARCY F.,
SEGONDY M.,
HUGUET M. F.,
SERRE A.
Publication year - 1992
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/j.1365-2249.1992.tb06890.x
Subject(s) - toxoplasma gondii , toxoplasmosis , peripheral blood mononuclear cell , immunology , antibody , antigen , immune system , seroconversion , biology , secretion , medicine , virology , in vitro , biochemistry
SUMMARY Antigen‐specific antibody secretion in vitro by peripheral blood mononuclear cells (PBMC) reflects an in vivo stimulation of the immune system by the antigen. Primary infection of immunocompetent patients with T. gondii causes an acute infection followed by chronic toxoplasmosis. We examined in vitro anti‐Toxoplasma antibody production by PBMC during the acute and chronic phases of toxoplasmosis. PBMC from patients with acute or chronic toxoplasmosis and seronegative subjects were cultured for up to 6 days. Anti‐Toxoplasma antibodies were assayed in supernatants by ELISA and immunoblotting. Anti‐Toxoplasma antibodies were detected in supernatants of PBMC from 29 pregnant women who seroconverted during gestation. PBMC from 17 patients who had chronic toxoplasmosis and PBMC from 10 seronegative healthy controls did not secrete Toxoplasma‐specific antibodies. This in vitro antibody secretion was spontaneous, active and transient since it disappeared between 11 and 24 weeks after seroconversion. Anti‐Toxoplasma antibody secretion by PBMC from patients with acute toxoplasmosis is consistent with an in vivo stimulation of the immune system by T. gondii antigens. Our results represent a new approach for studying the immunological response during T. gondii infection and could have important implications for the diagnosis of acute and re‐activated toxoplasmosis.